“Our planned flagship U.S. R&D and manufacturing center supports our commitment to fight for life for people living with cancer around the world, through state-of-the-art commercial-stage biologic pharmaceutical manufacturing, late-stage research and clinical development capabilities,” said John Oyler, Co-Founder, Chairman and CEO of BeiGene. “The Princeton- Hopewell area is an excellent location for BeiGene and the thriving life science community, with a deep talent pool as we continue to advance our pipeline of innovative cancer medicines and work to diversify our global supply chain.”
Tag:
Bonnie Watson-Coleman
-
-
PTC Therapeutics Inc., a South Plainfield-based biopharmaceutical company, cut the ribbon on its new Hopewell Township gene therapy manufacturing facility Thursday, October 14. The site is the former BMS site…